Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAnxiety is not listed as a common side effect of Mounjaro in the UK product information, but some people taking tirzepatide do report feeling more anxious, particularly in the early weeks of treatment. Knowing what is documented, what may have other explanations, and when to reach out to a clinician helps you manage treatment confidently. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability and discusses side effects with you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first place to look is the Mounjaro Summary of Product Characteristics (the SmPC) published on the electronic Medicines Compendium. It categorises side effects by frequency, and anxiety does not appear in the common or very common columns. The most frequently reported effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation and indigestion. Fatigue, headache and dizziness also appear. None of those are pleasant, but they are distinct from clinical anxiety.
That said, absence from the SmPC's frequency tables does not mean an effect is impossible. Regulatory listings reflect data from clinical trial populations and post-marketing surveillance up to a given cut-off date. The full picture of Mounjaro side effects continues to be monitored under the MHRA's Black Triangle (▼) scheme, which applies to all newer medicines and triggers enhanced safety reporting. If anxiety is something you experience, it is worth reporting — that is exactly the data the system needs.
The NHS tirzepatide medicines page is the clearest starting point for patients and lists what to watch for, including guidance on when to seek urgent help.
This is where the practical picture gets more nuanced. Several documented effects of tirzepatide can produce sensations that feel a lot like anxiety, even if the underlying mechanism is different.
Low blood sugar is one possibility. While hypoglycaemia is uncommon in people using Mounjaro without insulin or sulphonylureas, it can occur. The physical signs (racing heart, shakiness, sweating, a sense of unease) overlap almost completely with an anxiety response. If you notice this kind of feeling in the hours after eating less than usual, checking your blood glucose (if you have a monitor) and eating a small amount of carbohydrate is a sensible first response.
Disrupted sleep is another contributor. Nausea that worsens in the evening, or reflux that disturbs sleep, can leave you fatigued and emotionally raw. Fatigue alone can lower your threshold for anxious thoughts. Some people also find that rapid changes in appetite and eating patterns are psychologically unsettling, particularly if they have had a complicated relationship with food.
There is more detail on why tirzepatide might produce these feelings in the explanation of why Mounjaro can cause anxiety, and if you want to explore whether Mounjaro can cause anxiety in the first place, that page sets out what the evidence does and does not confirm. For a closer look at the relationship between Mounjaro and anxiety as it is currently understood, including the evidence specifically for tirzepatide and anxiety more broadly, both pages are worth reading together.
Most side effects, including those that affect mood, settle as your body adjusts over the first few weeks of a new dose. But some symptoms should not be left to resolve on their own.
Get same-day medical help if you experience: severe or worsening low mood, thoughts of self-harm, a new or significantly worsened anxiety disorder, or physical symptoms such as severe persistent stomach pain radiating to your back (which may suggest pancreatitis, a known but infrequent risk flagged in the MHRA's Drug Safety Update of January 2026).
Talk to a prescriber or GP (without waiting for it to become an emergency) if anxiety is persistent, is affecting your sleep or daily functioning, or feels out of proportion to anything going on in your life. Dose timing adjustments, a slower titration, or simply a careful review of all the medicines you take can sometimes resolve the issue. The prescribers at our clinical team cover exactly this kind of conversation as part of ongoing care, not just at the first consultation.
If you believe you are experiencing a side effect from Mounjaro, please report it to the MHRA Yellow Card scheme. That includes mood changes and anxiety. The scheme is open to patients as well as healthcare professionals, and reports genuinely influence how the medicine's safety profile is understood over time. Worth doing.
If anxiety has appeared since starting Mounjaro, or worsened since a dose increase, noting a few things before you speak to a prescriber will make the conversation more useful. When does it tend to happen, at a particular time of day, in relation to meals, or after a poor night's sleep? Has anything else changed (a new supplement, a different coffee brand, work stress)? How intense is it on a typical day, and has it changed over the past week?
That kind of record transforms a vague concern into a clinical conversation. A prescriber can then weigh up whether the feeling is likely to be treatment-related, dose-related, or independent of Mounjaro altogether. They can also consider whether psychological support alongside treatment would help, which is something our prescribers are happy to discuss as part of the full Mounjaro treatment picture.
If you are already considering treatment and want to ask about anxiety history or current mood before you begin, the free consultation is the right place to raise it. Suitability is assessed as a whole.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.